APrf Dan Peet

Associate Professor

School of Biological Sciences

College of Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.


Associate Professor Dan Peet's research interests are centred on understanding the molecular events within cells that underpin the genomic response to hypoxia. The cellular response to hypoxia is essential for many physiological processes in normal development and adult physiology, and contributes to the pathophysiology of major human diseases, including cancer, myocardial and cerebral ischaemia, pulmonary hypertension, and wound healing. The key components of this cellular response to hypoxia are a unique family of hydroxylase enzymes that act as the primary oxygen sensors, the Hypoxic Inducible transcription Factors (HIFs) that directly regulate gene expression, and specific target genes that mediate cellular changes. His research interests extend beyond the HIFs, to the identification and characterisation of novel substrates of the oxygen-sensing hydroxylases. Understanding these processes has major implications for the diagnosis, prognosis and novel therapeutic approaches to treat human disease. A more recent focus is on cellular metabolism, specifically the unusual metabolism displayed by proliferating cells, especially cancer cells, that mimic quiescent cells in hypoxia. Of particular interest are the photoreceptor cells in the retina, which also display cancer-like metabolism. A key aim is to determine what controls this unusual metabolism, and whether it is a similar mechanism of control to cancer cells, with important implications for retinal disease.

Date Position Institution name
2003 - ongoing Associate Professor University of Adelaide

Date Institution name Country Title
University of Melbourne Australia PhD

Year Citation
2026 Bersten, D. C., McDougal, D. P., Sullivan, A. E., Gerassimou, A., Breen, J., Fitzsimmons, R. L., . . . Whitelaw, M. L. (2026). Multimodal bHLH-PAS DNA binding controls specificity and drives obesity.. Nucleic Acids Research (NAR), 54(1), gkaf1352-1-gkaf1352-21.
DOI
2025 Allen, T. P., Roennfeldt, A. E., Reckdharajkumar, M., Sullivan, A. E., Liu, M., Quinn, R. J., . . . Bersten, D. C. (2025). dFLASH; dual FLuorescent transcription factor activity sensor for histone integrated live-cell reporting and high-content screening. Nature Communications, 16(1), 3298-1-3298-18.
DOI
2025 Hansman, D. S., Lim, K., Thomas, D., Casson, R. J., & Peet, D. J. (2025). Distinct metabolome and flux responses in the retinal pigment epithelium to cytokines associated with age-related macular degeneration: comparison of ARPE-19 cells and eyecups. Scientific Reports, 15(1), 13012-1-13012-17.
DOI
2024 Hansman, D. S., Ma, Y., Thomas, D., Smith, J. R., Casson, R. J., & Peet, D. (2024). Metabolic Reprogramming of the Retinal Pigment Epithelium by Cytokines Associated with Age-related Macular Degeneration. Bioscience Reports, 44(4), BSR20231904.-1-BSR20231904.-20.
DOI Scopus9 WoS10 Europe PMC10
2024 Hansman, D. S., Du, J., Casson, R. J., & Peet, D. J. (2024). Eye on the horizon: The metabolic landscape of the RPE in aging and disease. Progress in Retinal and Eye Research, 104, 101306-1-101306-62.
DOI Scopus13 WoS13 Europe PMC18
2023 Roennfeldt, A. E., Allen, T. P., Trowbridge, B. N., Beard, M. R., Whitelaw, M. L., Russell, D. L., . . . Peet, D. J. (2023). NanoFIRE: A NanoLuciferase and Fluorescent Integrated Reporter Element for Robust and Sensitive Investigation of HIF and Other Signalling Pathways. Biomolecules, 13(10), 1545-1-1545-16.
DOI
2022 Bersten, D. C., Sullivan, A. E., McDougal, D., Breen, J., Fitzsimmons, R. L., Muscat, G. E. O., . . . Whitelaw, M. L. (2022). Core and Flanking bHLH-PAS:DNA interactions mediate specificity and drive obesity.
DOI Europe PMC1
2022 Button, E. L., Rossi, J. J., McDougal, D. P., Bruning, J. B., Peet, D., Bersten, D., . . . Whitelaw, M. (2022). Characterization of functionally deficient SIM2 variants found in patients with neurological phenotypes.. The Biochemical journal, 479(13), 1441-1454.
DOI Scopus5 WoS3 Europe PMC3
2021 Rossi, J. J., Rosenfeld, J. A., Chan, K. M., Streff, H., Nankivell, V., Peet, D. J., . . . Bersten, D. C. (2021). Molecular characterisation of rare loss-of-function NPAS3 and NPAS4 variants identified in individuals with neurodevelopmental disorders.. Sci Rep, 11(1), 1-11.
DOI Scopus13 WoS10 Europe PMC8
2020 Newman, M., Moussavi Nik, S. H., Sutherland, G. T., Hin, N., Kim, W. S., Halliday, G. M., . . . Lardelli, M. (2020). Accelerated loss of hypoxia response in zebrafish with familial Alzheimer's disease-like mutation of Presenilin 1. Human Molecular Genetics, 29(14), 2379-2394.
DOI Scopus14 WoS11 Europe PMC11
2020 Haydinger, C. D., Kittipassorn, T., & Peet, D. J. (2020). Power to see-drivers of aerobic glycolysis in the mammalian retina: a review. Clinical and Experimental Ophthalmology, 48(8), 1057-1071.
DOI Scopus19 WoS16 Europe PMC16
2020 Rodriguez, J., Haydinger, C. D., Peet, D. J., Nguyen, L., & von Kriegsheim, A. (2020). Asparagine hydroxylation is a reversible post-translational modification. Mol Cell Proteomics, 19(11), 1777-1789.
DOI Scopus14 WoS14 Europe PMC15
2019 Kittipassorn, T., Haydinger, C. D., Wood, J. P. M., Mammone, T., Casson, R. J., & Peet, D. J. (2019). RNA sequencing data of cultured primary rat Müller cells, the spontaneously immortalized rat Müller cell line, SIRMu-1, and the SV40-transformed rat Müller cell line, rMC-1. Data in Brief, 23, 103721-1-103721-4.
DOI
2019 Hampton-Smith, R. J., Davenport, B. A., Nagarajan, Y., & Peet, D. J. (2019). The conservation and functionality of the oxygen-sensing enzyme Factor Inhibiting HIF (FIH) in non-vertebrates. PLoS ONE, 14(4), 0216134-1-0216134-29.
DOI Scopus11 WoS10 Europe PMC8
2019 Pickel, C., Günter, J., Ruiz-Serrano, A., Spielmann, P., Fabrizio, J. A., Wolski, W., . . . Scholz, C. C. (2019). Oxygen-dependent bond formation with FIH regulates the activity of the client protein OTUB1. Redox Biology, 26, 101265.
DOI Scopus19 WoS18 Europe PMC15
2019 Bersten, D. C., & Peet, D. J. (2019). When is a target not a target?. eLife, 8, e50585-1-e50585-3.
DOI Scopus6 WoS6 Europe PMC6
2019 Kittipassorn, T., Haydinger, C. D., Wood, J. P. M., Mammone, T., Casson, R. J., & Peet, D. J. (2019). Characterization of the novel spontaneously immortalized rat Müller cell line SIRMu-1. Experimental Eye Research, 181, 127-135.
DOI Scopus6 WoS6 Europe PMC6
2018 Sim, J., Cowburn, A. S., Palazon, A., Madhu, B., Tyrakis, P. A., Macias, D., . . . Johnson, R. S. (2018). The Factor Inhibiting HIF asparaginyl hydroxylase regulates oxidative metabolism and accelerates metabolic adaptation to hypoxia. Cell Metabolism, 27(4), 898-e.7.
DOI Scopus73 WoS70 Europe PMC64
2017 Vandyke, K., Zeissig, M., Hewett, D., Martin, S., Mrozik, K., Cheong, C., . . . Zannettino, A. (2017). HIF-2α promotes dissemination of plasma cells in multiple myeloma by regulating CXCL12/CXCR4 and CCR1. Cancer Research, 77(20), 5452-5463.
DOI Scopus50 WoS47 Europe PMC44
2017 Chen, D. Y., Fabrizio, J. A., Wilkins, S. E., Dave, K. A., Gorman, J. J., Gleadle, J. M., . . . Mercer, A. A. (2017). Ankyrin repeat proteins of orf virus influence the cellular hypoxia response pathway. Journal of Virology, 91(1), e01430-1-e01430-16.
DOI Scopus17 WoS16 Europe PMC14
2017 Peet, D., Kittipassorn, T., Wood, J., Chidlow, G., & Casson, R. (2017). HIF signalling: the eyes have it. Experimental Cell Research, 356(2), 136-140.
DOI Scopus23 WoS20 Europe PMC19
2017 Nagarajan, Y., Rychkov, G., & Peet, D. (2017). Modulation of TRP channel activity by hydroxylation and its therapeutic potential. Pharmaceuticals, 10(2), 35.
DOI Scopus9 WoS9 Europe PMC6
2016 Sullivan, A., Peet, D., & Whitelaw, M. (2016). MAGED1 is a novel regulator of a select subset of bHLH PAS transcription factors. FEBS Journal, 283(18), 3488-3502.
DOI Scopus10 WoS10 Europe PMC10
2016 Scholz, C., Rodriguez, J., Pickel, C., Burr, S., Fabrizio, J., Nolan, K., . . . Taylor, C. (2016). FIH regulates cellular metabolism through hydroxylation of the deubiquitinase OTUB1. PLoS Biology, 14(1), e1002347-1-e1002347-22.
DOI Scopus85 WoS81 Europe PMC74
2016 Casson, R., Wood, J., Han, G., Kittipassorn, T., Peet, D., & Chidlow, G. (2016). M-type pyruvate kinase isoforms and lactate dehydrogenase a in the mammalian retina: metabolic implications. Investigative Ophthalmology and Visual Science, 57(1), 66-80.
DOI Scopus45 WoS42 Europe PMC48
2015 Ng, S., Wood, J., Chidlow, G., Han, G., Kittipassorn, T., Peet, D., & Casson, R. (2015). Cancer-like metabolism of the mammalian retina. Clinical and Experimental Ophthalmology, 43(4), 367-376.
DOI Scopus88 WoS86 Europe PMC87
2015 Karttunen, S., Duffield, M., Scrimgeour, N., Squires, L., Lim, W., Dallas, M., . . . Peet, D. (2015). Oxygen-dependent hydroxylation by FIH regulates the TRPV3 ion channel. Journal of Cell Science, 128(2), 225-231.
DOI Scopus38 WoS38 Europe PMC32
2015 Kittipassorn, T., & Peet, D. J. (2015). Hypoxia inducible factor single nucleotide polymorphisms: exploring the role of HIF polymorphisms in retinal disease. Clinical and Experimental Ophthalmology, 43(1), 1-2.
DOI
2015 Kind, K., Tam, K., Banwell, K., Gauld, A., Russell, D., Macpherson, A., . . . Thompson, J. (2015). Oxygen-regulated gene expression in murine cumulus cells. Reproduction, Fertility and Development, 27(2), 407-418.
DOI Scopus17 WoS17 Europe PMC13
2015 Ng, S. K., Wood, J. P. M., Chidlow, G., Peet, D. J., & Casson, R. J. (2015). Potential adverse effects to the retina of cancer therapy targeting pyruvate kinase M2. Acta Oncologica, 54(1), 136-137.
DOI Scopus1 WoS1
2015 Kiesewetter, H., Becker, R., Breitkopf, M., Baumgarten, S., Halis, G., Höhne, A., . . . Zöllner, M. (2015). Treatment of high risk pregnancies. Phlebologie, 44(1), 7-13.
DOI Scopus2
2014 Sullivan, A., Raimondo, A., Schwab, T., Bruning, J., Froguel, P., Farooqi, I., . . . Whitelaw, M. (2014). Characterization of human variants in obesity-related SIM1 protein identifies a hot-spot for dimerization with the partner protein ARNT2. Biochemical Journal, 461(3), 403-412.
DOI Scopus9 WoS9 Europe PMC10
2014 Bersten, D., Bruning, J., Peet, D., & Whitelaw, M. (2014). Human variants in the Neuronal Basic Helix-Loop-Helix/ Per-Arnt-Sim (bHLH/PAS) transcription factor complex NPAS4/ARNT2 disrupt function. PLoS One, 9(1), e85768-1-e85768-11.
DOI Scopus22 WoS22 Europe PMC22
2013 Bersten, D., Sullivan, A., Peet, D., & Whitelaw, M. (2013). BHLH-PAS proteins in cancer. Nature Reviews. Cancer, 13(12), 827-841.
DOI Scopus220 WoS209 Europe PMC205
2013 Bonnefond, A., Raimondo, A., Stutzmann, F., Ghoussaini, M., Ramachandrappa, S., Bersten, D., . . . Froguel, P. (2013). Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi-like features. Journal of Clinical Investigation, 123(7), 3037-3041.
DOI Scopus119 WoS106 Europe PMC98
2013 Ramachandrappa, S., Raimondo, A., Cali, A., Keogh, J., Henning, E., Saeed, S., . . . Farooqi, I. (2013). Rare variants in single-minded 1 (SIM1) are associated with severe obesity. Journal of Clinical Investigation, 123(7), 3042-3050.
DOI Scopus141 WoS117 Europe PMC115
2013 Hao, N., Bhakti, V., Peet, D., & Whitelaw, M. (2013). Reciprocal regulation of the basic helix-loop-helix/Per-Arnt-Sim partner proteins, Arnt and Arnt2, during neuronal differentiation. Nucleic Acids Research, 41(11), 5626-5638.
DOI Scopus30 WoS27 Europe PMC28
2013 Ramachandrappa, S., Raimondo, A., Cali, A. M. G., Keogh, J. M., Henning, E., Saeed, S., . . . Farooqi, I. S. (2013). Erratum: Rare variants in single-minded 1 (SIM1) are associated with severe obesity (Journal of Clinical Investigation (2013) 123:7 (3042-3050) DOI: 10.1172/JCI68016). Journal of Clinical Investigation, 123(8), 3635.
DOI Scopus1
2012 Wilkins, S., Karttunen, S., Hampton-Smith, R., Murchland, I., Chapman-Smith, A., & Peet, D. (2012). Factor Inhibiting HIF (FIH) recognizes distinct molecular features within hypoxia-inducible factor-α (HIF-α) versus ankyrin repeat substrates. Journal of Biological Chemistry, 287(12), 8769-8781.
DOI Scopus27 WoS27 Europe PMC24
2012 Olechnowicz, S., Fedele, A., & Peet, D. (2012). Hypoxic induction of the regulator of G-protein signalling 4 gene is mediated by the hypoxia-inducible factor pathway. PLoS One, 7(9), 1-12.
DOI Scopus16 WoS17 Europe PMC14
2012 Yusuf, D., Olechnowicz, S., & Peet, D. (2012). The Transcription factor encyclopedia. Genome Biology, 13(3), R24:1-R24:25.
DOI Scopus100 WoS92 Europe PMC98
2011 Martin, S., Diamond, P., Gronthos, S., Peet, D., & Zannettino, A. (2011). The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma. Leukemia, 25(10), 1533-1542.
DOI Scopus111 WoS102 Europe PMC96
2010 Devries, I., Hampton-Smith, R., Mulvihill, M., Alverdi, V., Peet, D., & Komives, E. (2010). Consequences of IkappaB alpha hydroxylation by the factor inhibiting HIF (FIH). FEBS Letters, 584(23), 4725-4730.
DOI Scopus21 WoS21 Europe PMC19
2010 Tam, K., Russell, D., Peet, D., Bracken, C., Rodgers, R., Thompson, J., & Kind, K. (2010). Hormonally regulated follicle differentiation and luteinization in the mouse is associated with hypoxia inducible factor activity. Molecular and Cellular Endocrinology, 327(1-2), 47-55.
DOI Scopus44 WoS42 Europe PMC36
2010 Martin, S., Diamond, P., Williams, S., To, L., Peet, D., Fujii, N., . . . Zannettino, A. (2010). Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells. Haematologica, 95(5), 776-784.
DOI Scopus86 WoS79 Europe PMC69
2010 Zhang, N., Fu, Z., Karttunen, S., Chicher, J., Gorman, J., Visk, D., . . . Johnson, R. (2010). The asparaginyl hydroxylase factor inhibiting HIF-1α is an essential regulator of metabolism. Cell Metabolism, 11(5), 364-378.
DOI Scopus209 WoS208 Europe PMC181
2009 Hampton-Smith, R., & Peet, D. (2009). From polyps to people: A HIghly Familiar response to hypoxia. Annals of the New York Academy of Sciences, 1177(1), 19-29.
DOI Scopus38 WoS35 Europe PMC32
2009 Wilkins, S., Hyvarinen, J., Chicher, J., Gorman, J., Peet, D., Bilton, R., & Koivunen, P. (2009). Differences in hydroxylation and binding of Notch and HIF-1 alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1). International Journal of Biochemistry & Cell Biology, 41(7), 1563-1571.
DOI Scopus55 WoS50 Europe PMC47
2008 Lisy, K., & Peet, D. (2008). Turn me on: regulating HIF transcriptional activity. Cell Death and Differentiation, 15(4), 642-649.
DOI Scopus202 WoS186 Europe PMC162
2008 Zheng, X., Karttunen, S., Dias, J., Zheng, X., Gradin, K., Wallis, T., . . . Poellinger, L. (2008). Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proceedings of the National Academy of Sciences of the United States of America, 105(9), 3368-3373.
DOI Scopus223 WoS222 Europe PMC202
2008 Lisy, K., & Peet, D. J. (2008). Erratum: Turn me on: Regulating HIF transcriptional activity (Cell Death and Differentiation (2008) 10.1038/sj.cdd.4402315). Cell Death and Differentiation, 15(4), 805.
DOI
2007 Gorman, J. J., Wallis, T. P., Dave, K. A., Hamilton, B. R., Headlam, M. J., Linke, S., & Peet, D. J. (2007). Quantitative approaches for analysis of regulatory post-translational modifications. MOLECULAR & CELLULAR PROTEOMICS, 6(8), 15.
2007 Karttunen, S., Hampton-Smith, R., & Peet, D. (2007). Characterization of ankyrin repeat-containing proteins as substrates of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible transcription factor. Methods in Enzymology, 435, 61-85.
DOI Scopus25 WoS25 Europe PMC23
2006 Bracken, C., Fedele, A., Karttunen, S., Balrak, W., Lisy, K., Whitelaw, M., & Peet, D. (2006). Cell-specific regulation of hypoxia-inducible factor (HIF)-1α and HIF-2α stabilization and transactivation in a graded oxygen environment. Journal of Biological Chemistry, 281(32), 22575-22585.
DOI Scopus192 WoS188 Europe PMC171
2005 Bracken, C., Whitelaw, M., & Peet, D. (2005). Activity of hypoxia-inducible factor 2α is regulated by association with the NF-κB essential modulator. Journal of Biological Chemistry, 280(14), 14240-14251.
DOI Scopus62 WoS60 Europe PMC55
2004 Peet, D., Lando, D., Whelan, D., Whitelaw, M., & Gorman, J. (2004). Oxygen-dependent asparagine hydroxylation. Methods in Enzymology, 381, 467-487.
DOI Scopus22 WoS18 Europe PMC11
2004 Karttunen, S., Stojkoski, C., Kewley, R., Booker, G., Whitelaw, M., & Peet, D. (2004). Substrate requirements of the oxygen-sensing asparaginyl hydroxylase factor-inhibiting hypoxia-inducible factor. Biological Chemistry, 279(14), 14391-14397.
DOI Scopus71 WoS65 Europe PMC54
2003 Bracken, C., Whitelaw, M., & Peet, D. (2003). The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cellular and Molecular Life Sciences, 60(7), 1376-1393.
DOI Scopus224 WoS206 Europe PMC186
2003 Lees, M., Peet, D., & Whitelaw, M. (2003). Defining the role for XAP2 in stabilization of the dioxin receptor. Journal of Biological Chemistry, 278(38), 35878-35888.
DOI Scopus82 WoS68 Europe PMC58
2003 Lando, D., Gorman, J., Whitelaw, M., & Peet, D. (2003). Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation. FEBS Journal, 270(5), 781-790.
DOI Scopus123 WoS105 Europe PMC87
2002 Fedele, A., Whitelaw, M., & Peet, D. (2002). Regulation of gene expression by the hypoxia-inducible factors. Molecular Interventions, 2(4), 229-243.
DOI Scopus77 Europe PMC57
2002 Lando, D., Peet, D., Pongratz, I., & Whitelaw, M. (2002). Mammalian two-hybrid assay showing redox control of HIF-like factor. Methods in Enzymology, 353, 3-10.
DOI Scopus3 WoS3 Europe PMC2
2002 Lando, D., Peet, D., Gorman, J., Whelan, D., Whitelaw, M., & Bruick, R. (2002). FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes & Development, 16(12), 1466-1471.
DOI Scopus1345 WoS1280 Europe PMC1144
2002 Lando, D., Peet, D., Whelan, D., Gorman, J., & Whitelaw, M. (2002). Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch. Science, 295(5556), 858-861.
DOI Scopus1371 WoS1283 Europe PMC1100
1999 Peet, D. J., & Pryor, M. D. (1999). Evaluation of a MOSFET radiation sensor for the measurement of entrance surface dose in diagnostic radiology. BRITISH JOURNAL OF RADIOLOGY, 72(858), 562-568.
DOI WoS60 Europe PMC44
1998 Peet, D. J., Janowski, B. A., & Mangelsdorf, D. J. (1998). The LXRs: A new class of oxysterol receptors. Current Opinion in Genetics and Development, 8(5), 571-575.
DOI Scopus332 WoS310 Europe PMC261
1998 Peet, D. J., Turley, S. D., Ma, W., Janowski, B. A., Lobaccaro, J. M. A., Hammer, R. E., & Mangelsdorf, D. J. (1998). Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα. Cell, 93(5), 693-704.
DOI Scopus1309 WoS1264 Europe PMC1102
1998 Peet, D. J., Doyle, D. F., Corey, D. R., & Mangelsdorf, D. J. (1998). Engineering novel specificities for ligand-activated transcription in the nuclear hormone receptor RXR. Chemistry and Biology, 5(1), 13-21.
DOI Scopus48 WoS43 Europe PMC33
1998 Corey, D. R., Doyle, D. F., Peet, D. J., & Mangelsdorf, D. J. (1998). Engineering novel specificities for ligand dependent transcriptional activation. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 216, U256.
1998 Doyle, D. F., Peet, D. J., Mangelsdorf, D. J., & Corey, D. R. (1998). Changing the ligand-binding specificity of the nuclear hormone receptor RXR.. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 215, U876.
1996 Jones, L. N., Peet, D. J., Danks, D. M., Negri, A. P., & Rivett, D. E. (1996). Hairs from patients with maple syrup urine disease show a structural defect in the fiber cuticle. Journal of Investigative Dermatology, 106(3), 461-464.
DOI Scopus39 WoS31 Europe PMC20
1996 Negri, A. P., Peet, D. J., Rivett, D. E., Rivett, R. E. H., & Cornell, H. J. (1996). Covalently Bound Fatty Acids and Ceramides in Wool. Journal of the Textile Institute, 87(3), 608-611.
DOI Scopus2
1995 Peet, D. J., Rivett, D. E., & Wettenhall, R. E. H. (1995). The Chemistry of the Cuticle Surface of Keratin Fibers. Textile Research Journal, 65(1), 58-59.
DOI Scopus28 WoS22
1992 Peet, D. J., Wettenhall, R. E. H., Rivett, D. E., & Allen, A. K. (1992). A comparative study of covalently-bound fatty acids in keratinized tissues. Comparative Biochemistry and Physiology Part B Biochemistry and, 102(2), 363-366.
DOI Scopus28 WoS24 Europe PMC6

Year Citation
2017 Zeissig, M. N., Hewett, D. R., Martin, S., Mrozik, K. M., Cheong, C. M., Diamond, P., . . . Zannettino, A. C. W. (2017). HIF-2α Upregulates CCR1 to Promote Dissemination of Plasma Cells in Multiple Myeloma. In BLOOD Vol. 130 (pp. 2 pages). Atlanta, GA: AMER SOC HEMATOLOGY.
2015 Scholz, C., Rodriguez, J., Von Kriegsheim, A., Fabrizio, J., Pickel, C., Cavadas, M., . . . Taylor, C. (2015). FIH regulates cellular metabolism through hydroxylation of the deubiquitinating enzyme OTUB1. In ACTA PHYSIOLOGICA Vol. 213 (pp. 54). WILEY-BLACKWELL.
2006 Duchen, M., Semenza, G. L., Ratcliffe, P. J., López-Barneo, J., Prabhakar, N., Acker, H., . . . Archer, S. L. (2006). Discussion. In Novartis Foundation Symposium Vol. 272 (pp. 8-14).
2006 Ratcliffe, P. J., Peet, D., Chandel, N. S., Semenza, G. L., Stolze, I. P., Pouysségur, J., . . . Schumacker, P. T. (2006). Discussion. In Novartis Foundation Symposium Vol. 272 (pp. 49-53).
2006 Murphy, M. P., Schumacker, P. T., Kummer, W., Archer, S. L., Harris, A. L., Sylvester, J. T., . . . Peet, D. (2006). Discussion. In Novartis Foundation Symposium Vol. 272 (pp. 192-195).
2005 Peet, D. J. (2005). Cellular response to hypoxia: A key role for oxygen-sensing peptidyl hydroxylases. In JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY Vol. 39 (pp. 568-569). Perth, AUSTRALIA: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD.
1999 Rivett, D. E., & Peet, D. J. (1999). Fatty acids chemically bound to protein forms the hydrophic membrane of the hair cuticle. In Experimental Dermatology Vol. 8 (pp. 360-361). Denmark.

Year Citation
2016 Scholz, C. C., Rodriguez, J., Pickel, C., Burr, S., Fabrizio, J. -A., Nolan, K. A., . . . Taylor, C. T. (2016). FIH regulates cellular metabolism through hydroxylation of the deubiquitinase OTUB1. Poster session presented at the meeting of ACTA PHYSIOLOGICA. WILEY-BLACKWELL.
2009 Lisy, K., & Peet, D. J. (2009). Is FIH-1 Phosphorylated? 2-DE Analysis of FIH-1 Isoforms. Poster session presented at the meeting of Hypoxia and Consequences: From Molecule to Malady. New York, New York.
2007 Lisy, K., & Peet, D. J. (2007). Regulation of Gene Expression via the Asparaginyl Hydroxylase Factor Inhibiting HIF (FIH-1). Poster session presented at the meeting of Lorne Cancer Conference. Lorne, Australia.
2006 Lisy, K., & Peet, D. J. (2006). Characterising Expression of the Asparaginyl Hydroxylase Factor Inhibiting HIF (FIH-1). Poster session presented at the meeting of Lorne Genome Conference. Lorne, Australia.
2005 Lisy, K., & Peet, D. J. (2005). Characterisation of FIH-1 Expression. Poster session presented at the meeting of Australian Society for Biochemistry and Molecular Biology ComBio Conference. Adelaide, Australia.

Year Citation
2019 Chey, Y. C. J. (2019). Generation and Transcriptomic Analysis of HIF-1Alpha and HIF-2Alpha Knockout 5TGM1 Multiple Myeloma Cells. (Master's Thesis).

Year Citation
- Roennfeldt, A., Allen, T., Trowbridge, B., Beard, M., Whitelaw, M., Russell, D., . . . Peet, D. (n.d.). Graph Pad prism files of all data published in Roennfeldt et al. (2023). Data points for each experiment represents the mean of an individual replicate (and thus each experiment was completed in triplicate with the mean +/- standard deviation graphed)..
DOI

Year Citation
2023 Allen, T., Roennfeldt, A., Reckdharajkumar, M., Liu, M., Quinn, R., Russell, D., . . . Bersten, D. (2023). dFLASH; dual FLuorescent transcription factor Activity Sensor for Histone integrated live-cell reporting and high-content screening.
DOI

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Principal Supervisor Development of lead compounds for therapeutic inhibition of FIH. Doctor of Philosophy Doctorate Full Time Ms An Cao
2025 Principal Supervisor Characterising Endocrine Disrupting Chemicals and Synthetic Agonists as Peroxisome Proliferator Activated Receptor Ligands. Doctor of Philosophy Doctorate Full Time Mr Samuel Luke Wallis
2025 Principal Supervisor Characterising Endocrine Disrupting Chemicals and Synthetic Agonists as Peroxisome Proliferator Activated Receptor Ligands. Doctor of Philosophy Doctorate Full Time Mr Samuel Luke Wallis
2025 Principal Supervisor Development of lead compounds for therapeutic inhibition of FIH. Doctor of Philosophy Doctorate Full Time Ms An Cao
2022 Principal Supervisor Developing cell-based screening systems to identify small molecule inhibitors of the hypoxic signalling protein FIH, and to investigate the signalling pathways of ovulation. Doctor of Philosophy Doctorate Full Time Miss Alison Elizabeth Roennfeldt
2022 Principal Supervisor Developing cell-based screening systems to identify small molecule inhibitors of the hypoxic signalling protein FIH, and to investigate the signalling pathways of ovulation. Doctor of Philosophy Doctorate Full Time Miss Alison Elizabeth Roennfeldt

Date Role Research Topic Program Degree Type Student Load Student Name
2021 - 2025 Principal Supervisor The Influence of Metabolic Substrates and Inflammatory Cytokines on Retinal Pigment Epithelium Metabolism Doctor of Philosophy Doctorate Full Time Mr David Sean Hansman
2021 - 2025 Co-Supervisor Understanding the impact of hypoxia and associated signalling pathways on ZIKV and DENV replication and innate antiviral responses Doctor of Philosophy Doctorate Full Time Miss Brooke Nyree Trowbridge
2019 - 2024 Co-Supervisor Development and application of dual fluorescent reporting systems for HIF-1 alpha and other transcription factor pathways Doctor of Philosophy Doctorate Full Time Mr Timothy Patrick Allen
2019 - 2023 Co-Supervisor The structural selectivity and various ligands of PPAR gamma Doctor of Philosophy Doctorate Full Time Mr Benjamin Soon Kai Chua
2019 - 2025 Co-Supervisor A Structural Analysis of Estrogen Receptor Evolution and Allosteric Regulation Doctor of Philosophy Doctorate Full Time Mr Daniel Patrick McDougal
2017 - 2020 Principal Supervisor Generation and Transcriptomic Analysis of HIF-1Alpha and HIF-2Alpha Knockout 5TGM1 Multiple Myeloma Cells Master of Philosophy Master Full Time Dr Yu Chinn Joshua Chey
2017 - 2023 Co-Supervisor Characterisation of Ovarian Cancer Development, Progression and Treatment Resistance Through Mass Spectrometry Analysis Doctor of Philosophy Doctorate Full Time Mr Mitchell Aidan Acland
2017 - 2022 Principal Supervisor Molecular Drivers of Aerobic Glycolysis in the Mammalian Retina Doctor of Philosophy Doctorate Full Time Mr Cameron David Haydinger
2015 - 2021 Co-Supervisor Investigating mechanisms and biological functions of the bHLH/PAS transcription factors SIM1 and ARNT2 Doctor of Philosophy Doctorate Full Time Miss Alexis Georgia Gerassimou
2014 - 2020 Principal Supervisor Investigating the Warburg effect and the role of pyruvate kinase M2 in retinal Müller glial cells Doctor of Philosophy Doctorate Full Time Miss Thaksaon Kittipassorn
2013 - 2018 Principal Supervisor Characterising Novel Substrates of the Asparaginyl Hydroxylase FIH Doctor of Philosophy Doctorate Full Time Miss Jacqueline-Alba Fabrizio
2012 - 2018 Co-Supervisor Regulation of Sphingosine Kinase 1 Oncogenic Signalling by Calcium and Integrin Binding Proteins Doctor of Philosophy Doctorate Part Time Ms Wenying Zhu
2011 - 2018 Principal Supervisor Investigating the Role of HIF-1 and HIF-2 Transcription Factors in Multiple Myeloma Doctor of Philosophy Doctorate Full Time Miss Natalia Magdalena Martin
2009 - 2016 Co-Supervisor Function and Regulation of Single-minded 1 and Single-minded 2 Transcription Factors in Disease Doctor of Philosophy Doctorate Full Time Ms Adrienne Sullivan
2007 - 2012 Principal Supervisor Characterising Ankyrin Repeat Proteins as Substrates of the Asparaginyl Hydroxylase FIH Doctor of Philosophy Doctorate Full Time Miss Sarah Wilkins
2006 - 2012 Principal Supervisor Regulation of the Rgs4 Gene by the Hypoxia Inducible Factors Doctor of Philosophy Doctorate Full Time Mr Sam Olechnowicz
2006 - 2014 Co-Supervisor Regulation of Expression and Activity of the bHLH-PAS Transcription Factor NPAS4 Doctor of Philosophy Doctorate Full Time Dr David Bersten
2005 - 2011 Principal Supervisor Investigating Potential Post-Translational Modification of Factor-Inhibiting HIF (FIH-1) Doctor of Philosophy Doctorate Full Time Ms Karolina Lisy
2005 - 2016 Principal Supervisor Identification and Characterisation of Novel Substrates and Binding Partners of the Asparaginyl Hydroxylase, FIH Doctor of Philosophy Doctorate Part Time Miss Rachel Jane Hampton-Smith
2004 - 2008 Principal Supervisor Substrate Specificity of Factor Inhibiting HIF-1 (FIH-1) Doctor of Philosophy Doctorate Full Time Dr Sarah Karttunen
2004 - 2009 Co-Supervisor Gene Regulatory and Pro-Tumourigenic Mechanisms of the bHLH-PAS Transcription Factor SIM2s Doctor of Philosophy Doctorate Full Time Ms Alexandra Farrall
2003 - 2005 Co-Supervisor Differential Function and Regulation of the Hypoxia Inducible Factors in the Rat Pheochromocytoma Cell Line Pc12 Doctor of Philosophy Doctorate Full Time Mr Anthony Olind Fedele
2001 - 2005 Co-Supervisor Characterising the Differential Regulation of Hypoxia-Inducible Factor 1a and 2a Doctor of Philosophy Doctorate Full Time APrf Cameron Bracken

Date Role Membership Country
2009 - 2011 Member New York Academy of Sciences -
2004 - ongoing Member American Society of Biochemistry and Molecular Biology United States
2004 - ongoing Member Federation of American Societies for Experimental Biology United States
1990 - ongoing Member Australian Society of Biochemistry and Molecular Biology Australia

Date Role Editorial Board Name Institution Country
2015 - ongoing Consulting Editor Journal of Hypoxia University of Adelaide Australia

Connect With Me

External Profiles

Other Links